| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 684440 | Null | 0.00104257542638397 | 0.31774092 |
| NSC 735334 | Null | 0.00104257542638397 | 0.40348177 |
| NSC 33530 | Null | 0.0013187520236934 | 0.48244807 |
| NSC 646125 | Null | 0.0013187520236934 | 0.49720688 |
| NSC 674196 | Null | 0.0013187520236934 | 0.56140409 |
| NSC 690271 | ANTINEOPLASTIC-690271 | 0.0013187520236934 | 0.46912852 |
| NSC 726768 | 5,6-Dihydro-6-[(4-tert-butyloxycarbonylamino)-1-butyl]-5,11- dioxo-11H-indeno[1,2-c]isoquinoline | 0.0013187520236934 | 0.4281512 |
| NSC 732317 | 6,7-dichloro-2-methyl-3-(phenylthio)quinoxaline 1,4-dioxide | 0.00131875202369342 | 0.67625867 |
| NSC 327182 | L-Glutamic acid, N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]benzoyl]- | 0.00134664791567076 | 0.42130141 |
| NSC 371488 | 9-(3,4-dichlorophenyl)-2,7-bis((dimethylamino)methyl)-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2H)-dione, dihydrochloride | 0.00134664791567076 | 0.42086772 |